Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,966
Closed -$51.1K 246
2024
Q4
$51.1K Buy
2,966
+1,473
+99% +$29.4K 0.01% 440
2024
Q3
$33.7K Buy
+1,493
New +$34.2K 0.01% 512
2019
Q4
Sell
-17,323
Closed -$398K 182
2019
Q3
$398K Sell
17,323
-9,630
-36% -$220K 0.19% 117
2019
Q2
$654K Buy
26,953
+6,493
+32% +$134K 0.3% 86
2019
Q1
$265K Sell
20,460
-770
-4% -$13.5K 0.13% 155
2018
Q4
$320K Sell
21,230
-35,064
-62% -$907K 0.16% 132
2018
Q3
$2.21M Buy
56,294
+6,395
+13% +$288K 0.89% 36
2018
Q2
$2.46M Sell
49,899
-843
-2% -$47.8K 1.12% 29
2018
Q1
$3.03M Sell
50,742
-843
-2% -$56.2K 1.38% 19
2017
Q4
$4.06M Sell
51,585
-2,521
-5% -$203K 1.75% 11
2017
Q3
$4.54M Sell
54,106
-775
-1% -$55K 1.92% 9
2017
Q2
$3.59M Buy
54,881
+2,074
+4% +$141K 1.64% 14
2017
Q1
$3.84M Buy
52,807
+8,153
+18% +$536K 1.79% 9
2016
Q4
$2.62M Buy
+44,654
New +$2.36M 1.69% 11

Other funds holding ADNT

Oarsman Capital's ADNT Position: Q1 2025 in Review

Oarsman Capital sold out of Adient (ADNT) in Q1 2025, closing a stake of 2,966 shares — an estimated $51.1K sold.

Oarsman Capital first reported a position in ADNT in Q4 2016 and held it in 14 quarters. The position peaked at $4.54M in Q3 2017. 270 funds tracked by Wall St. Rank hold ADNT as of Q1 2025.

  • Oarsman Capital reported no remaining Adient position as of Q1 2025 after selling out during the quarter.
  • Oarsman Capital sold 2,966 Adient shares in Q1 2025, an estimated $51.1K.
  • Oarsman Capital first reported a position in Adient in Q4 2016 and held it in 14 quarters.
  • Oarsman Capital's Adient position peaked at $4.54M in Q3 2017.
  • 270 funds tracked by Wall St. Rank held Adient as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.